Islet lymphocyte subsets in male and female NOD mice are qualitatively similar but quantitatively distinct

References

• Bendelac A, Carnaud C, Boitard C, Bach JF. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. J Exp Med. 1987; 166 4: 823–832.
   PubMed Web of Science ®Google Scholar
• Miller BJ, Appel MC, O'Neil JJ, Wicker LS. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol. 1988; 140 1: 52–58.
   PubMed Web of Science ®Google Scholar
• Christianson SW, Shultz LD, Leiter EH. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes. 1993; 42 1: 44–55.
   PubMed Web of Science ®Google Scholar
• Pozzilli P, Signore A, Williams AJK, Beales PE. NOD mouse coloies around the world-recent facts and figures. Immunol Today. 1993; 14 5: 193–196.
   PubMedGoogle Scholar
• Delovitch TL, Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD. Immunity. 1997; 7 6: 727–738.
   PubMed Web of Science ®Google Scholar
• Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: As good as it gets?. Nat Med. 1999; 5 6: 601–604.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick F, Lepault F, Homo-Delarche F, Bach JF, Dardenne M. Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse. Endocrinology. 1991; 129 3: 1382–1390.
   PubMed Web of Science ®Google Scholar
• Fox HS. Androgen treatment prevents diabetes in nonobese diabetic mice. J Exp Med. 1992; 175 5: 1409–1412.
   PubMed Web of Science ®Google Scholar
• Toyoda H, Takei S, Formby B. Effect of 5-alpha dihydrotestosterone on T-cell proliferation of the female nonobese diabetic mouse. Proc Soc Exp Biol Med. 1996; 213 3: 287–293.
   PubMed Web of Science ®Google Scholar
• Pearce RB, Formby B, Healy K, Peterson CM. Association of an androgen-responsive T cell phenotype with murine diabetes and Idd2. Autoimmunity. 1995; 20 4: 247–258.
   PubMed Web of Science ®Google Scholar
• Ablamunits V, Elias D, Cohen IR. The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse. Clin Exp Immunol. 1999; 115 2: 260–267.
   PubMed Web of Science ®Google Scholar
• Bao M, Yang Y, Jun HS, Yoon JW. Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol. 2002; 168 10: 5369–5375.
   PubMed Web of Science ®Google Scholar
• Fox CJ, Danska JS. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice. J Immunol. 1997; 158 5: 2414–2424.
   PubMed Web of Science ®Google Scholar
• Maier LM, Wicker LS. Genetic susceptibility to type 1 diabetes. Curr Opin Immunol. 2005; 17 6: 601–608.
   PubMed Web of Science ®Google Scholar
• Cornall RJ, Prins JB, Todd JA, Pressey A, DeLarato NH, Wicker LS, Peterson LB. Type 1 diabetes in mice is linked to the interleukin-1 receptor and Lsh/Ity/Bcg genes on chromosome 1. Nature. 1991; 353 6341: 262–265.
   PubMed Web of Science ®Google Scholar
• Wong FS, Visintin I, Wen L, Flavell RA, Janeway CAJr. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med. 1996; 183 1: 67–76.
   PubMed Web of Science ®Google Scholar
• Lund T, O'Reilly L, Hutchings P, Kanagawa O, Simpson E, Gravely R, Chandler P, Dyson J, Picard JK, Edwards A, . Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain. Nature. 1990; 345 6277: 727–729.
   PubMed Web of Science ®Google Scholar
• Nishimoto H, Kikutani H, Yamamura K, Kishimoto T. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature. 1987; 328 6129: 432–434.
   PubMed Web of Science ®Google Scholar
• Wang B, Gonzalez A, Benoist C, Mathis D. The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus. Eur J Immunol. 1996; 26 8: 1762–1769.
   PubMed Web of Science ®Google Scholar
• Serreze DV, Leiter EH, Christianson GJ, Greiner D, Roopenian DC. Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes. 1994; 43 3: 505–509.
   PubMed Web of Science ®Google Scholar
• Katz J, Benoist C, Mathis D. Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur J Immunol. 1993; 23 12: 3358–3360.
   PubMed Web of Science ®Google Scholar
• Wicker LS, Leiter EH, Todd JA, Renjilian RJ, Peterson E, Fischer PA, Podolin PL, Zijlstra M, Jaenisch R, Peterson LB. Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes. 1994; 43 3: 500–504.
   PubMed Web of Science ®Google Scholar
• Utsugi T, Yoon JW, Park BJ, Imamura M, Averill N, Kawazu S, Santamaria P. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo. Diabetes. 1996; 45 8: 1121–1131.
   PubMed Web of Science ®Google Scholar
• Nagata M, Santamaria P, Kawamura T, Utsugi T, Yoon JW. Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta-cells in nonobese diabetic mice. J Immunol. 1994; 152 4: 2042–2050.
   PubMed Web of Science ®Google Scholar
• Kurts C, Carbone FR, Krummel MF, Koch KM, Miller JF, Heath WR. Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells. Nature. 1999; 398 6725: 341–344.
   PubMed Web of Science ®Google Scholar
• Adorini L, Gregori S, Harrison LC. Understanding autoimmune diabetes: Insights from mouse models. Trends Mol Med. 2002; 8 1: 31–38.
   PubMed Web of Science ®Google Scholar
• Wucherpfennig KW, Eisenbarth GS. Type 1 diabetes. Nat Immunol. 2001; 2 9: 767–768.
   PubMed Web of Science ®Google Scholar
• Mellanby RJ, Thomas D, Phillips JM, Cooke A. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells. Immunology. 2007; 121 1: 15–28.
   PubMed Web of Science ®Google Scholar
• Serreze DV, Wasserfall C, Ottendorfer EW, Stalvey M, Pierce MA, Gauntt C, O'Donnell B, Flanagan JB, Campbell-Thompson M, Ellis TM, . Diabetes acceleration or prevention by a coxsackievirus B4 infection: Critical requirements for both interleukin-4 and gamma interferon. J Virol. 2005; 79 2: 1045–1052.
   PubMed Web of Science ®Google Scholar
• Serreze DV, Chapman HD, Post CM, Johnson EA, Suarez-Pinzon WL, Rabinovitch A. Th1 to Th2 cytokine shifts in nonobese diabetic mice: Sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. J Immunol. 2001; 166 2: 1352–1359.
   PubMed Web of Science ®Google Scholar
• Pop SM, Wong CP, Culton DA, Clarke SH, Tisch R. Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes. J Exp Med. 2005; 201 8: 1333–1346.
   PubMed Web of Science ®Google Scholar
• Mohrs M, Shinkai K, Mohrs K, Locksley RM. Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity. 2001; 15 2: 303–311.
   PubMed Web of Science ®Google Scholar
• Wakeland E, Morel L, Achey K, Yui M, Longmate J. Speed congenics: A classic technique in the fast lane (relatively speaking). Immunol Today. 1997; 18 10: 472–477.
   PubMedGoogle Scholar
• Wong CP, Li L, Frelinger JA, Tisch R. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice. J Immunol. 2006; 176 3: 1637–1644.
   PubMed Web of Science ®Google Scholar
• Zhao R, Loftus DJ, Appella E, Collins EJ. Structural evidence of T cell xeno-reactivity in the absence of molecular mimicry. J Exp Med. 1999; 189 2: 359–370.
   PubMed Web of Science ®Google Scholar
• Amrani A, Serra P, Yamanouchi J, Trudeau JD, Tan R, Elliott JF, Santamaria P. Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation. J Immunol. 2001; 167 2: 655–666.
   PubMed Web of Science ®Google Scholar
• Gallichan WS, Balasa B, Davies JD, Sarvetnick N. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. J Immunol. 1999; 163 3: 1696–1703.
   PubMed Web of Science ®Google Scholar
• Mueller R, Krahl T, Sarvetnick N. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med. 1996; 184 3: 1093–1099.
   PubMed Web of Science ®Google Scholar
• Mohrs K, Harris DP, Lund FE, Mohrs M. Systemic dissemination and persistence of Th2 and type 2 cells in response to infection with a strictly enteric nematode parasite. J Immunol. 2005; 175 8: 5306–5313.
   PubMed Web of Science ®Google Scholar
• Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev. 2003; 2 3: 119–125.
   PubMed Web of Science ®Google Scholar
• Anderson MS, Bluestone JA. The NOD mouse: A model of immune dysregulation. Annu Rev Immunol. 2005; 23:447–485.
   PubMed Web of Science ®Google Scholar
• Goldrath AW, Barber L, Chen KE, Alters SE. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse. J Autoimmun. 1995; 8 2: 209–220.
   PubMed Web of Science ®Google Scholar
• Wang B, Gonzalez A, Hoglund P, Katz JD, Benoist C, Mathis D. Interleukin-4 deficiency does not exacerbate disease in NOD mice. Diabetes. 1998; 47 8: 1207–1211.
   PubMed Web of Science ®Google Scholar
• Trudeau JD, Kelly-Smith C, Verchere CB, Elliott JF, Dutz JP, Finegood DT, Santamaria P, Tan R. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest. 2003; 111 2: 217–223.
   PubMed Web of Science ®Google Scholar
• Lieberman SM, Evans AM, Han B, Takaki T, Vinnitskaya Y, Caldwell JA, Serreze DV, Shabanowitz J, Hunt DF, Nathenson SG, . Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc Natl Acad Sci USA. 2003; 100 14: 8384–8388.
   PubMed Web of Science ®Google Scholar
• Enee E, Martinuzzi E, Blancou P, Bach JM, Mallone R, van Endert P. Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice. J Immunol. 2008; 180 8: 5430–5438.
   PubMed Web of Science ®Google Scholar
• Tian J, Zekzer D, Lu Y, Dang H, Kaufman DL. B cells are crucial for determinant spreading of T cell autoimmunity among beta cell antigens in diabetes-prone nonobese diabetic mice. J Immunol. 2006; 176 4: 2654–2661.
   PubMed Web of Science ®Google Scholar
• McDonald KG, McDonough JS, Newberry RD. Adaptive immune responses are dispensable for isolated lymphoid follicle formation: Antigen-naive, lymphotoxin-sufficient B lymphocytes drive the formation of mature isolated lymphoid follicles. J Immunol. 2005; 174 9: 5720–5728.
   PubMed Web of Science ®Google Scholar